Dr Keith Heslinger OBGYN Flint, MI - Flint OBGYN

Dr Heslinger

Keith A. Heslinger MD, FACOG

With over 30 years of experience, Dr. Heslinger is highly experienced in both traditional as well as the newest technological procedures. A native of Flint, Michigan, Dr. Heslinger obtained his BS from the University of Michigan, attended Wayne State University School of Medicine and then completed his internship and residency from Balboa Naval Hospital in San Diego, California. After his discharge from the US Navy as a lieutenant commander, he returned to fulfill his dream of serving the women of Flint and the surrounding areas.

Dr. Heslinger is board certified in OB/GYN and has years of experience in obstetrics, well woman care, and gynecological abnormalities affecting women of all age groups. He is certified in the newest Laparoscopic, pelvic and Robotic surgeries. His special field of interest is Urogynecological evaluation and treatments. He is currently taking new patients.

DR. HESLINGER'S CREDENTIALS

Dr Heslinger

Board Certification:

OB/GYN – ACOG Nov 1995
Recertification, December 2020

Experience:

Women’s Integrated Health Care, P.C. 2000 – 9/2020
Genesys Regional Medical Center 1998 – 2000
McLaren OB/GYN Associates 7/1996 – 3/1998
Naval Medical Center, San Diego, CA 6/1993 – 6/1996

Education:

Obstetrics & Gynecology Residency, Naval Medical Center, San Diego, CA 1993
Doctor of Medicine, Wayne State University, Detroit, MI 1989
Bachelor of Science in Biology, University of Michigan, Flint, MI 1985

Professional Societies:

American Congress of Obstetricians & Gynecologists
American Medical Association
Michigan State Medical Society

Additional Training:

Robotic surgery training and certification 2019
New Techniques in Pelvic Floor Reconstruction 2006
Cystoscopy training and Urogynecological cystoscopy privileges 2007
Placement & implantation of neuromodulator for overactive bladder 2007

Research:

Bayer Healthcare / an open-label, non-randomized, prospective
observational cohort study to assess Post-procedural outcomes in
two cohorts of women who undergo either hysteroscopic
sterilization (Essure) or laparoscopic tubal sterilization.
Essure / Novasure study sponsored by Bayer Healthcare
Essure Permanent sterilization device modification.